6/9/2025Kelun-Biotech Secures US$250M in Upsized HK Share Placement

6/9/2025Everest Presents Positive Results from Phase 1b/2a Trial of EVER001 fo...

6/9/2025Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted

6/9/2025China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs

6/9/2025CDE Solicits Comments on Draft Guidance on Post-Approval Change Manage...

6/9/2025YolTech's YOLT‑101 Wins FDA IND Clearance as China Licensee Salubris ...

6/9/2025Livzon's siRNA Candidate YJH‑012 Approved for Clinical Entry in China

6/9/2025Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hypertension

6/7/2025Recent Executive Moves

6/7/2025QureBio Secures ~CNY 100M in Series C1 Financing to Advance BsAb Thera...

6/6/2025Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...

More>>

6/9/2025Following FDA's Elsa, China Accelerates AI Health Regulations: What Yo...

6/5/2025China Ascends to Global Leadership in Oncology R&D: IQVIA

6/5/2025Mainland Chinese Market for Weight Loss and Diabetes Drugs to Soon Be ...

6/4/2025Driving Business Growth Through Investment Funds: Analyses and Practic...

6/2/20252025 Outlook for Medtech in China (Simon Kucher)

5/22/2025China's Clinical Trial Boom (Asimov Press)

5/20/2025'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...

5/20/2025How Trump's Proposed Price Cuts Could Hurt China's Innovative Drugmake...

5/16/2025US Tariffs on Pharmaceuticals Could Hit Chinese Export Firms’ Profit ...

5/16/2025SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...

5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...

More>>